Company intelligence / Profile preview

DelCure LifeSciences

Mumbai, Maharashtra, India

Ownership: Private
Development stage: Other

Overview

DelCure LifeSciences has launched more than 60 brands in India, focused on differentiated drug delivery, pain management, and specialty formulations, often bringing first-in-India products to market via international partnerships, but there are no reports of formal clinical trials akin to biotech originators[3][1].

Therapeutic areas: ImmunologyRheumatologyInfectious DiseasesNeurologyMetabolic Disorders
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

Pharma Base (Switzerland)Amarillo Biosciences (USA)Cymbiotics (USA)Helixor (Germany)Akums Drugs & Pharmaceuticals (strategic manufacturing collaboration)

Beyond the preview

Go deeper on DelCure LifeSciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DelCure LifeSciences.

Explore the full profile